Copyright © 2004 by the European Society of Cardiology.
Editorial
BNP or echocardiography for monitoring heart failure?
Division of Cardiology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, SAR
* Correspondence to: Professor John E Sanderson, Department of Medicine and Therapeutics, 9th Fl Clinical Science Bldg, Prince of Wales Hospital, Hong Kong, SAR. Tel.: +852 2632 2064; fax: +852 2637 2396 (E-mail: jesanderson@cuhk.edu.hk).
| The first 10% of the full text of this article appears below. |
This editorial refers to "Comparison of echocardiography and plasma B-type natriuretic peptide for monitoring the response to treatment in acute heart failure"
by A. Gackowski et al. on
page 1788
No-one would question the value of echocardiography for the initial assessment of patients with heart failure and it is now a mandatory investigation. Not only can the cause be frequently correctly identified, but important prognostic information can also be gleaned. In particular, the restrictive filling pattern seen with the Doppler mitral inflow velocities is recognized to be associated with a poor prognosis, especially if it does not normalize with initial treatment.1 The restrictive filling pattern is also associated with higher atrial natriuretic peptide (ANP) and brain natriuretic peptide levels (BNP) and both peptides correlate inversely
![]()
CiteULike
Connotea
Del.icio.us What's this?
Related articles in EHJ:
- Comparison of echocardiography and plasma B-type natriuretic peptide for monitoring the response to treatment in acute heart failure
- Andrzej Gackowski, Richard Isnard, Jean-Louis Golmard, Françoise Pousset, Alain Carayon, Gilles Montalescot, Jean-Sébastien Hulot, Daniel Thomas, Wieslawa Piwowarska, and Michel Komajda
EHJ 2004 25: 1788-1796.[Abstract] [FREE Full Text]